Tilray Brands Launches New Beer Pub Light
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Should l Buy TLRY?
Pub Beer, the beer brand by Tilray Brands, announced the launch of Pub Light. "We took everything we love about Pub Beer, tore it apart, built it back better, and landed on a brand-new recipe that's lighter, and easier," said Moo Eakin, Senior Brand Manager, Pub Beer. "It's cold, crisp and the beer you wish you grabbed sooner."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TLRY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 6.140
Low
8.50
Averages
9.57
High
10.00
Current: 6.140
Low
8.50
Averages
9.57
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. It operates through four segments: cannabis operations, beverage operations, distribution operations, and the wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The beverage operations, which encompasses the production, marketing and of beverage products. The distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers. The Wellness products, which encompasses wellness and better-for-you foods and beverages. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, Chowie Wowie and others. It supports over 40 brands in over 20 countries, including cannabis offerings, hemp-based foods and craft beverages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tilray Brands Stock Rises After Upgrade Following Q3 Earnings
- International Business Growth: Tilray's international segment saw approximately 73% year-over-year growth in Q3 FY26, contributing over a third of the company's total revenue, indicating strong performance in global markets that is expected to drive overall company results further.
- Capacity Enhancement Potential: Analyst William Kirk noted that Tilray's international business is at an inflection point, with plans to increase capacity from the current 137 metric tons to around 200 metric tons, which will significantly enhance the company's competitive position and profitability.
- Canadian Market Stability: As supply shifts to international markets, Tilray's core Canadian business is experiencing significantly less price pressure, maintaining its market share leadership, indicating that the company's robust domestic performance lays a solid foundation for future growth.
- Optimistic Outlook: Kirk maintains a $10 price target for Tilray, believing that the stock's recovery since July 2025, along with management's strategy to slow down share issuance, has bolstered market confidence in its future, especially against a backdrop of potential regulatory improvements.
See More
Altria: A High-Yield Investment in Tobacco Amid Cannabis Interest
- Strong Profitability: Altria Group generates over $20 billion in annual revenue, maintaining a high net margin of 75.86% despite the long-term decline in cigarette consumption, showcasing robust financial resilience in a competitive market.
- Dividend King Status: With a 56-year streak of increasing dividends and a current yield of 6.39%, Altria remains a favorite among investors, particularly those seeking high-yield opportunities, further solidifying its market position.
- Strategic Transformation: The company has launched its 'Moving Beyond Smoking' strategy, aiming to double revenue from next-generation tobacco products to $5 billion by 2028; despite regulatory challenges and competitive pressures, this transformation indicates a forward-looking approach to future markets.
- Investment in Cannabis Market: Altria invested approximately $1.8 billion in Canadian cannabis company Cronos in 2019, holding a 41% stake; although its current value is only $429 million, the potential for significant returns increases as marijuana legalization progresses.
See More
Tilray's Q3 Results Mixed Amid Regulatory Concerns
- Rating Upgrade: Roth Capital upgraded Tilray's rating from 'Neutral' to 'Overweight' while maintaining a $10 price target, indicating confidence in the company's international growth despite regulatory uncertainties looming over the industry.
- Earnings Highlights: Tilray reported a 19% year-over-year revenue increase to $206.7 million, surpassing the $201.3 million expectation, while net loss significantly narrowed to $25.2 million, reflecting improvements in business fundamentals.
- Market Reaction: Despite the positive earnings report, TLRY shares fell 1.5% in early Thursday trading, highlighting investor concerns regarding increasing regulatory restrictions on cannabis products in the U.S.
- Analyst Sentiment: While Alliance Global lowered its price target on TLRY to $7, the overall analyst outlook remains cautious, with 7 out of 10 analysts rating the stock as 'Hold', indicating a divergence in views on future growth potential.
See More
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
Tilray Reports 19% Revenue Growth in Q3, Driven by International Sales Surge
- Surge in International Sales: Tilray's Q3 revenue climbed 19% to $206.7 million, driven by a remarkable 73% increase in international sales to $64.8 million, demonstrating strong demand in global markets and solidifying its position in the international cannabis sector.
- Significant Loss Reduction: The company's net loss narrowed dramatically from $793.5 million a year ago to $25.2 million, with loss per share improving to $0.24, although it fell short of the consensus estimate of $0.14, reflecting progress in cost control and operational efficiency.
- EBITDA Outlook Reaffirmed: Tilray reaffirmed its FY2026 EBITDA outlook between $62 million and $72 million, indicating confidence in future profitability, despite a 24% decline in beverage revenue to $42.6 million, with management remaining optimistic about international expansion.
- Investor Sentiment Shift: Following the strong earnings report, Tilray's shares jumped 4% on Wednesday, while retail investor sentiment on Stocktwits shifted from 'neutral' to 'extremely bullish', indicating market recognition of the company's growth potential.
See More
Tilray Reports Significant Narrowing of Q3 Net Loss
- Narrowed Net Loss: Tilray reported a net loss of $26.57 million for Q3, translating to $0.24 per share, significantly reduced from a staggering net loss of $789.86 million or $8.69 per share in the same quarter last year, indicating improvements in cost management and operational efficiency.
- Adjusted Net Income Positive: The adjusted net income for the quarter was $0.02 per share, compared to an adjusted net loss of $0.03 per share in the prior-year quarter, suggesting a positive shift in profitability that may attract more investor interest.
- Revenue Growth: The company achieved an 11% increase in net revenue, reaching $206.73 million compared to $185.78 million in the same quarter last year, reflecting strong performance in market demand and product sales.
- Stock Price Surge: In pre-market trading on Wednesday, Tilray's stock rose by $0.32, or 4.95%, indicating a positive market reaction to the earnings report, which could further boost investor confidence.
See More
Tilray Brands Stock Rises After Upgrade Following Q3 Earnings
- International Business Growth: Tilray's international segment saw approximately 73% year-over-year growth in Q3 FY26, contributing over a third of the company's total revenue, indicating strong performance in global markets that is expected to drive overall company results further.
- Capacity Enhancement Potential: Analyst William Kirk noted that Tilray's international business is at an inflection point, with plans to increase capacity from the current 137 metric tons to around 200 metric tons, which will significantly enhance the company's competitive position and profitability.
- Canadian Market Stability: As supply shifts to international markets, Tilray's core Canadian business is experiencing significantly less price pressure, maintaining its market share leadership, indicating that the company's robust domestic performance lays a solid foundation for future growth.
- Optimistic Outlook: Kirk maintains a $10 price target for Tilray, believing that the stock's recovery since July 2025, along with management's strategy to slow down share issuance, has bolstered market confidence in its future, especially against a backdrop of potential regulatory improvements.
See More
Altria: A High-Yield Investment in Tobacco Amid Cannabis Interest
- Strong Profitability: Altria Group generates over $20 billion in annual revenue, maintaining a high net margin of 75.86% despite the long-term decline in cigarette consumption, showcasing robust financial resilience in a competitive market.
- Dividend King Status: With a 56-year streak of increasing dividends and a current yield of 6.39%, Altria remains a favorite among investors, particularly those seeking high-yield opportunities, further solidifying its market position.
- Strategic Transformation: The company has launched its 'Moving Beyond Smoking' strategy, aiming to double revenue from next-generation tobacco products to $5 billion by 2028; despite regulatory challenges and competitive pressures, this transformation indicates a forward-looking approach to future markets.
- Investment in Cannabis Market: Altria invested approximately $1.8 billion in Canadian cannabis company Cronos in 2019, holding a 41% stake; although its current value is only $429 million, the potential for significant returns increases as marijuana legalization progresses.
See More
Tilray's Q3 Results Mixed Amid Regulatory Concerns
- Rating Upgrade: Roth Capital upgraded Tilray's rating from 'Neutral' to 'Overweight' while maintaining a $10 price target, indicating confidence in the company's international growth despite regulatory uncertainties looming over the industry.
- Earnings Highlights: Tilray reported a 19% year-over-year revenue increase to $206.7 million, surpassing the $201.3 million expectation, while net loss significantly narrowed to $25.2 million, reflecting improvements in business fundamentals.
- Market Reaction: Despite the positive earnings report, TLRY shares fell 1.5% in early Thursday trading, highlighting investor concerns regarding increasing regulatory restrictions on cannabis products in the U.S.
- Analyst Sentiment: While Alliance Global lowered its price target on TLRY to $7, the overall analyst outlook remains cautious, with 7 out of 10 analysts rating the stock as 'Hold', indicating a divergence in views on future growth potential.
See More
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
Tilray Reports 19% Revenue Growth in Q3, Driven by International Sales Surge
- Surge in International Sales: Tilray's Q3 revenue climbed 19% to $206.7 million, driven by a remarkable 73% increase in international sales to $64.8 million, demonstrating strong demand in global markets and solidifying its position in the international cannabis sector.
- Significant Loss Reduction: The company's net loss narrowed dramatically from $793.5 million a year ago to $25.2 million, with loss per share improving to $0.24, although it fell short of the consensus estimate of $0.14, reflecting progress in cost control and operational efficiency.
- EBITDA Outlook Reaffirmed: Tilray reaffirmed its FY2026 EBITDA outlook between $62 million and $72 million, indicating confidence in future profitability, despite a 24% decline in beverage revenue to $42.6 million, with management remaining optimistic about international expansion.
- Investor Sentiment Shift: Following the strong earnings report, Tilray's shares jumped 4% on Wednesday, while retail investor sentiment on Stocktwits shifted from 'neutral' to 'extremely bullish', indicating market recognition of the company's growth potential.
See More
Tilray Reports Significant Narrowing of Q3 Net Loss
- Narrowed Net Loss: Tilray reported a net loss of $26.57 million for Q3, translating to $0.24 per share, significantly reduced from a staggering net loss of $789.86 million or $8.69 per share in the same quarter last year, indicating improvements in cost management and operational efficiency.
- Adjusted Net Income Positive: The adjusted net income for the quarter was $0.02 per share, compared to an adjusted net loss of $0.03 per share in the prior-year quarter, suggesting a positive shift in profitability that may attract more investor interest.
- Revenue Growth: The company achieved an 11% increase in net revenue, reaching $206.73 million compared to $185.78 million in the same quarter last year, reflecting strong performance in market demand and product sales.
- Stock Price Surge: In pre-market trading on Wednesday, Tilray's stock rose by $0.32, or 4.95%, indicating a positive market reaction to the earnings report, which could further boost investor confidence.
See More
